Lymphodepletion strategies to potentiate adoptive T-cell immunotherapy – what are we doing; where are we going?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lymphodepletion strategies to potentiate adoptive T-cell immunotherapy – what are we doing; where are we going?

Published:2020-12-28 Issue:5 Volume:21 Page:627-637
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Bechman Natasha¹^ORCID,Maher John²³⁴⁵

Affiliation:

1. Warwick Medical School, Medical School Building, Coventry;

2. Leucid Bio Ltd., Guy’s Hospital, London UK

3. King’s College London, School of Cancer and Pharmaceutical Sciences, Guy’s Cancer Centre, London UK

4. Department of Clinical Immunology and Allergy, King’s College Hospital NHS Foundation Trust, London UK

5. Department of Immunology, Eastbourne Hospital, Kings Drive, East Sussex, UK

Funder

J Maher’s laboratory is supported by Leucid Bio, Breast Cancer Now, British Lung Foundation, the Wellcome Trust

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2021.1857361

Reference107 articles.

1. TREATMENT OF PRIMARY FIBROSARCOMA IN THE RAT WITH IMMUNE LYMPHOCYTES

2. Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma

3. Chimeric antigen receptor T-cell therapies for lymphoma

4. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

5. The immunological basis of endotoxin-induced tumor regression. Requirement for a pre-existing state of concomitant anti-tumor immunity.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GD2 targeting CAR T cells for neuroblastoma;EJC Paediatric Oncology;2024-12

2. Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells;Journal for ImmunoTherapy of Cancer;2024-06

3. Long-term efficacy of adoptive cell therapy is determined by host CD8⁺T cells and undermined by lymphodepleting preconditioning;2024-05-21

4. Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors;Cancer Cell International;2024-04-15

5. Challenges and considerations in the immunotherapy of DLL3-positive small-cell lung cancer using IL-18 armoured chimeric antigen receptor T-cells;Translational Lung Cancer Research;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3